Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Seer, Inc. engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software. The company intends to sell its products for research purposes.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $656,000.00 | $6.6M | $15.5M | $16.7M | $14.2M | $16.6M |
| Gross profit | $656,000.00 | $3.4M | $7.1M | $8.5M | $7.1M | $8.5M |
| Operating income | -$33.6M | -$71.5M | -$97.2M | -$103.5M | -$100.1M | -$78.0M |
| Net income | -$32.8M | -$71.2M | -$93.0M | -$86.3M | -$86.6M | -$73.6M |
| Diluted EPS | -$2.48 | -$1.17 | -$1.49 | -$1.35 | — | — |
| Operating cash flow | -$20.8M | -$46.3M | -$60.8M | -$59.1M | -$46.1M | -$44.4M |
| Free cash flow | -$25.4M | -$53.3M | -$71.0M | -$66.4M | -$49.7M | -$46.2M |
| Gross margin | 100.0% | 51.6% | 45.8% | 51.1% | 49.8% | 51.1% |
| Operating margin | -5129.4% | -1080.1% | -627.6% | -621.0% | -706.4% | -470.5% |
| Net margin | -4996.2% | -1075.5% | -600.1% | -517.8% | -611.1% | -444.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1M | $4.0M | $4.0M | $4.2M | $4.1M | $4.1M | $4.2M | $2.8M |
| Gross profit | $1.7M | $1.9M | $2.0M | $2.1M | $2.1M | $2.1M | $2.2M | $982,000.00 |
| Operating income | -$27.1M | -$24.3M | -$23.5M | -$20.7M | -$20.5M | -$19.3M | -$17.4M | -$17.3M |
| Net income | -$22.9M | -$21.3M | -$21.7M | -$19.9M | -$19.4M | -$18.2M | -$16.0M | -$16.8M |
| Diluted EPS | -$0.35 | -$0.35 | — | — | — | — | — | — |
| Operating cash flow | -$10.1M | -$14.1M | -$11.5M | -$11.4M | -$14.7M | -$7.6M | -$10.8M | -$15.4M |
| Free cash flow | -$11.2M | -$16.3M | -$12.0M | -$12.1M | -$15.2M | -$7.8M | -$11.1M | -$15.7M |
| Gross margin | 56.3% | 48.1% | 50.6% | 49.0% | 52.1% | 51.2% | 52.0% | 35.2% |
| Operating margin | -882.0% | -603.3% | -587.2% | -493.0% | -506.8% | -469.4% | -413.8% | -617.8% |
| Net margin | -743.8% | -529.0% | -543.6% | -474.4% | -479.5% | -442.5% | -380.7% | -602.8% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-08 | Nishar Dipchand | Sale | 10,660 | $2.18 | $23,265.45 | filing |
| 2026-05-20 | Horn David R.· PRESIDENT & CFO | Sale | 7,303 | $1.69 | $12,351.56 | filing |
| 2026-05-08 | Bazarko Anthony R.· Chief Commercial Officer | Award | 75,000 | — | — | filing |
| 2026-02-18 | Farokhzad Omid· CEO AND CHAIR | Sale | 24,385 | $1.99 | $48,645.64 | filing |
| 2026-02-18 | Horn David R.· PRESIDENT & CFO | Sale | 7,743 | $1.99 | $15,446.51 | filing |
| 2026-02-03 | Horn David R.· PRESIDENT & CFO | Award | 79,000 | $0.00 | $0.00 | filing |
| 2026-02-03 | Farokhzad Omid· CEO AND CHAIR | Award | 697,162 | $0.00 | $0.00 | filing |
| 2025-12-09 | MCGUIRE TERRANCE | C | 4,088 | — | — | filing |
| 2025-12-09 | Farokhzad Omid· CEO AND CHAIR | C | 1,438,057 | — | — | filing |
| 2025-12-09 | Farokhzad Omid· CEO AND CHAIR | C | 2,117,138 | — | — | filing |
| 2025-11-19 | Farokhzad Omid· CEO AND CHAIR | Sale | 33,838 | $1.97 | $66,708.23 | filing |
| 2025-11-19 | Horn David R.· PRESIDENT & CFO | Sale | 6,797 | $1.97 | $13,399.61 | filing |
| 2025-09-02 | Ro Isaac | Award | 41,000 | $0.00 | $0.00 | filing |
| 2025-08-20 | Farokhzad Omid· CEO AND CHAIR | Sale | 33,992 | $2.04 | $69,483.05 | filing |
| 2025-08-20 | Horn David R.· PRESIDENT & CFO | Sale | 6,827 | $2.04 | $13,955.07 | filing |
| 2025-07-07 | MCGUIRE TERRANCE | Award | 20,500 | $0.00 | $0.00 | filing |
| 2025-07-07 | LANGER ROBERT | Award | 20,500 | $0.00 | $0.00 | filing |
| 2025-07-07 | Gulyani Meeta | Award | 20,500 | $0.00 | $0.00 | filing |
| 2025-07-07 | Roelofs Nicolas H PHD | Award | 17,083 | $0.00 | $0.00 | filing |
| 2025-07-07 | Nishar Dipchand | Award | 20,500 | $0.00 | $0.00 | filing |
Latest 20 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.